• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人二肽基肽酶 III 与两种底物相互作用的分子动力学模拟研究。

Molecular Dynamics Simulations Study of the Interactions between Human Dipeptidyl-Peptidase III and Two Substrates.

机构信息

Key Laboratory for Molecular Enzymology and Engineering of Ministry of Education, National Engineering Laboratory for AIDS Vaccine, School of Life Science, Jilin University, Changchun 130012, China.

出版信息

Molecules. 2021 Oct 27;26(21):6492. doi: 10.3390/molecules26216492.

DOI:10.3390/molecules26216492
PMID:34770898
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8587566/
Abstract

Human dipeptidyl-peptidase III (hDPP III) is capable of specifically cleaving dipeptides from the N-terminal of small peptides with biological activity such as angiotensin II (Ang II, DRVYIHPF), and participates in blood pressure regulation, pain modulation, and the development of cancers in human biological activities. In this study, 500 ns molecular dynamics simulations were performed on free-hDPP III (PDB code: 5E33), hDPP III-Ang II (PDB code: 5E2Q), and hDPP III-IVYPW (PDB code: 5E3C) to explore how these two peptides affect the catalytic efficiency of enzymes in terms of the binding mode and the conformational changes. Our results indicate that in the case of the hDPP III-Ang II complex, subsite S1 became small and hydrophobic, which might be propitious for the nucleophile to attack the substrate. The structures of the most stable conformations of the three systems revealed that Arg421-Lys423 could form an α-helix with the presence of Ang II, but only part of the α-helix was produced in hDPP III-IVYPW. As the hinge structure in hDPP III, the conformational changes that took place in the Arg421-Lys423 residue could lead to the changes in the shape and space of the catalytic subsites, which might allow water to function as a nucleophile to attack the substrate. Our results may provide new clues to enable the design of new inhibitors for hDPP III in the future.

摘要

人二肽基肽酶 III(hDPP III)能够特异性地从小肽的 N 端切割具有生物活性的二肽,如血管紧张素 II(Ang II,DRVYIHPF),并参与血压调节、疼痛调制以及人类生物活性中癌症的发展。在这项研究中,对游离 hDPP III(PDB 代码:5E33)、hDPP III-Ang II(PDB 代码:5E2Q)和 hDPP III-IVYPW(PDB 代码:5E3C)进行了 500 ns 的分子动力学模拟,以探讨这两种肽如何通过结合模式和构象变化来影响酶的催化效率。我们的结果表明,在 hDPP III-Ang II 复合物的情况下,底物结合口袋 S1 变得更小且更疏水,这可能有利于亲核试剂攻击底物。三个系统最稳定构象的结构表明,Arg421-Lys423 在有 Ang II 存在的情况下可以形成一个α-螺旋,但在 hDPP III-IVYPW 中只产生了部分α-螺旋。作为 hDPP III 的铰链结构,Arg421-Lys423 残基发生的构象变化可能导致催化口袋的形状和空间发生变化,这可能允许水作为亲核试剂攻击底物。我们的结果可能为未来设计 hDPP III 的新抑制剂提供新的线索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b620/8587566/1c22d5666a99/molecules-26-06492-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b620/8587566/23795b8b4691/molecules-26-06492-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b620/8587566/2bb41765429f/molecules-26-06492-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b620/8587566/0b64b262396d/molecules-26-06492-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b620/8587566/58e5ea567fc9/molecules-26-06492-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b620/8587566/259702599ab1/molecules-26-06492-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b620/8587566/52e6a5f7deb7/molecules-26-06492-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b620/8587566/f625d88367fe/molecules-26-06492-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b620/8587566/3be165eec515/molecules-26-06492-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b620/8587566/106983d9e1d0/molecules-26-06492-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b620/8587566/172e6eac4930/molecules-26-06492-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b620/8587566/3199430a0fe0/molecules-26-06492-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b620/8587566/1c22d5666a99/molecules-26-06492-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b620/8587566/23795b8b4691/molecules-26-06492-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b620/8587566/2bb41765429f/molecules-26-06492-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b620/8587566/0b64b262396d/molecules-26-06492-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b620/8587566/58e5ea567fc9/molecules-26-06492-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b620/8587566/259702599ab1/molecules-26-06492-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b620/8587566/52e6a5f7deb7/molecules-26-06492-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b620/8587566/f625d88367fe/molecules-26-06492-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b620/8587566/3be165eec515/molecules-26-06492-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b620/8587566/106983d9e1d0/molecules-26-06492-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b620/8587566/172e6eac4930/molecules-26-06492-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b620/8587566/3199430a0fe0/molecules-26-06492-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b620/8587566/1c22d5666a99/molecules-26-06492-g012.jpg

相似文献

1
Molecular Dynamics Simulations Study of the Interactions between Human Dipeptidyl-Peptidase III and Two Substrates.人二肽基肽酶 III 与两种底物相互作用的分子动力学模拟研究。
Molecules. 2021 Oct 27;26(21):6492. doi: 10.3390/molecules26216492.
2
Aprotinin interacts with substrate-binding site of human dipeptidyl peptidase III.抑肽酶与人二肽基肽酶 III 的底物结合部位相互作用。
J Biomol Struct Dyn. 2019 Sep;37(14):3596-3606. doi: 10.1080/07391102.2018.1521343. Epub 2019 Jan 13.
3
Substrate complexes of human dipeptidyl peptidase III reveal the mechanism of enzyme inhibition.人二肽基肽酶III的底物复合物揭示了酶抑制机制。
Sci Rep. 2016 Mar 30;6:23787. doi: 10.1038/srep23787.
4
Validation of flavonoids as potential dipeptidyl peptidase III inhibitors: Experimental and computational approach.黄酮类化合物作为潜在二肽基肽酶 III 抑制剂的验证:实验和计算方法。
Chem Biol Drug Des. 2017 Apr;89(4):619-627. doi: 10.1111/cbdd.12887. Epub 2016 Nov 19.
5
Novel dipeptidyl hydroxamic acids that inhibit human and bacterial dipeptidyl peptidase III.新型二肽基羟肟酸抑制人源和细菌二肽基肽酶 III。
J Enzyme Inhib Med Chem. 2016;31(sup2):40-45. doi: 10.1080/14756366.2016.1186021. Epub 2016 May 26.
6
Dynamic properties of dipeptidyl peptidase III from Bacteroides thetaiotaomicron and the structural basis for its substrate specificity - a computational study.来自嗜热栖热放线菌的二肽基肽酶III的动力学特性及其底物特异性的结构基础——一项计算研究
Mol Biosyst. 2017 Oct 24;13(11):2407-2417. doi: 10.1039/c7mb00310b.
7
Aspartate 496 from the subsite S2 drives specificity of human dipeptidyl peptidase III.来自亚位点S2的天冬氨酸496决定了人二肽基肽酶III的特异性。
Biol Chem. 2015 Apr;396(4):359-66. doi: 10.1515/hsz-2014-0247.
8
Unravelling the inhibitory zinc ion binding site and the metal exchange mechanism in human DPP III.揭示人源二肽基肽酶 III 的抑制性锌离子结合位点和金属交换机制。
Phys Chem Chem Phys. 2021 Jun 16;23(23):13267-13275. doi: 10.1039/d1cp01302e.
9
Human dipeptidyl peptidase III regulates G-protein coupled receptor-dependent Ca2+ concentration in human embryonic kidney 293T cells.人二肽基肽酶III调节人胚肾293T细胞中G蛋白偶联受体依赖性钙离子浓度。
Biol Chem. 2016 Jun 1;397(6):563-9. doi: 10.1515/hsz-2016-0117.
10
Human dipeptidyl peptidase III mRNA variant I and II are expressed concurrently in multiple tumor derived cell lines and translated at comparable efficiency in vitro.人二肽基肽酶III mRNA变体I和II在多种肿瘤衍生细胞系中同时表达,并且在体外以相当的效率进行翻译。
Mol Biol Rep. 2016 Jun;43(6):457-62. doi: 10.1007/s11033-016-3996-9. Epub 2016 May 6.

引用本文的文献

1
Molecular Modelling in Bioactive Peptide Discovery and Characterisation.生物活性肽发现与表征中的分子建模
Biomolecules. 2025 Apr 3;15(4):524. doi: 10.3390/biom15040524.
2
DPP3: From biomarker to therapeutic target of cardiovascular diseases.二肽基肽酶3:从生物标志物到心血管疾病的治疗靶点
Front Cardiovasc Med. 2022 Oct 12;9:974035. doi: 10.3389/fcvm.2022.974035. eCollection 2022.

本文引用的文献

1
Coumarin Derivatives Act as Novel Inhibitors of Human Dipeptidyl Peptidase III: Combined In Vitro and In Silico Study.香豆素衍生物作为人二肽基肽酶III的新型抑制剂:体外和计算机模拟联合研究
Pharmaceuticals (Basel). 2021 Jun 5;14(6):540. doi: 10.3390/ph14060540.
2
Unravelling the inhibitory zinc ion binding site and the metal exchange mechanism in human DPP III.揭示人源二肽基肽酶 III 的抑制性锌离子结合位点和金属交换机制。
Phys Chem Chem Phys. 2021 Jun 16;23(23):13267-13275. doi: 10.1039/d1cp01302e.
3
Dipeptidyl-peptidase 3 protects oxygen-glucose deprivation/reoxygenation-injured hippocampal neurons by suppressing apoptosis, oxidative stress and inflammation via modulation of Keap1/Nrf2 signaling.
二肽基肽酶 3 通过调节 Keap1/Nrf2 信号通路抑制细胞凋亡、氧化应激和炎症,从而保护氧葡萄糖剥夺/复氧损伤的海马神经元。
Int Immunopharmacol. 2021 Jul;96:107595. doi: 10.1016/j.intimp.2021.107595. Epub 2021 Mar 31.
4
Influence of Ionic Strength on Hydrophobic Interactions in Water: Dependence on Solute Size and Shape.离子强度对水中疏水相互作用的影响:取决于溶质的大小和形状。
J Phys Chem B. 2020 Nov 19;124(46):10326-10336. doi: 10.1021/acs.jpcb.0c06399. Epub 2020 Nov 4.
5
Binding of dipeptidyl peptidase III to the oxidative stress cell sensor Kelch-like ECH-associated protein 1 is a two-step process.二肽基肽酶 III 与氧化应激细胞传感器 Kelch 样 ECH 相关蛋白 1 的结合是一个两步过程。
J Biomol Struct Dyn. 2021 Nov;39(18):6870-6881. doi: 10.1080/07391102.2020.1804455. Epub 2020 Aug 18.
6
Dipeptidyl peptidase 3 modulates the renin-angiotensin system in mice.二肽基肽酶 3 在小鼠体内调节肾素-血管紧张素系统。
J Biol Chem. 2020 Oct 2;295(40):13711-13723. doi: 10.1074/jbc.RA120.014183. Epub 2020 Jun 16.
7
Absence of Dipeptidyl Peptidase 3 Increases Oxidative Stress and Causes Bone Loss.二肽基肽酶 3 缺失增加氧化应激并导致骨丢失。
J Bone Miner Res. 2019 Nov;34(11):2133-2148. doi: 10.1002/jbmr.3829. Epub 2019 Sep 9.
8
How Does Chirality Determine the Selective Inhibition of Histone Deacetylase 6? A Lesson from Trichostatin A Enantiomers Based on Molecular Dynamics.手性如何决定组蛋白去乙酰化酶 6 的选择性抑制?基于分子动力学的曲古抑菌素 A 对映体的教训。
ACS Chem Neurosci. 2019 May 15;10(5):2467-2480. doi: 10.1021/acschemneuro.8b00729. Epub 2019 Feb 26.
9
Aprotinin interacts with substrate-binding site of human dipeptidyl peptidase III.抑肽酶与人二肽基肽酶 III 的底物结合部位相互作用。
J Biomol Struct Dyn. 2019 Sep;37(14):3596-3606. doi: 10.1080/07391102.2018.1521343. Epub 2019 Jan 13.
10
Computational identification of the binding mechanism of a triple reuptake inhibitor amitifadine for the treatment of major depressive disorder.用于治疗重度抑郁症的三重再摄取抑制剂阿米法丁结合机制的计算鉴定
Phys Chem Chem Phys. 2018 Feb 28;20(9):6606-6616. doi: 10.1039/c7cp07869b.